Frontlight ResearchEarly access
Chronic kidney disease trials in United Kingdom
23 of 40 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleImlifidase Prior to Kidney Transplant in Highly Sensitised Children
- Where
- London
- Age
- 1 year to 17 years
- People
- 10 worldwide
- Run by
- Hansa Biopharma AB
See details and how to joinNCT05753930 · EU 2022-500230-28-00 - Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Bradford, Bristol, Canterbury, Cardiff, Dundee, Glasgow, Hounslow, London, Salford, Swansea
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Birmingham, Blackpool, Bromborough, Newcastle, Newquay, Poole, Rotherham, Torpoint
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - Phase 2Taking peopleSafety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
- Where
- Glasgow, Liverpool
- Age
- 12 years to 18 years
- People
- 18 worldwide
- Run by
- Vifor Fresenius Medical Care Renal Pharma
See details and how to joinNCT06593392 · EU 2023-509909-74-00 - No phaseTaking peopleA Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing Haemodialysis
- Where
- Derby, London, Manchester
- Age
- 18 years and over
- People
- 84
- Run by
- Imperial College London
See details and how to joinNCT07422532 - No phaseTaking peopleStreamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
- Where
- Oxford
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Medtronic Vascular
See details and how to joinNCT07115953 - Phase 2Taking peopleDose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
- Where
- London
- Age
- 18 years to 80 years
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07830719 · EU 2026-525974-21-00 - Phase 3CompletedA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Cambridge, Leicester, London, Newcastle upon Tyne, Salford
- Age
- 18 years to 100 years
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - Phase 3Taking peopleA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Glasgow, London, Manchester, Nottingham
- Age
- 1 year to 18 years
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - Phase 3Taking peopleA Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Where
- Aberdeen, Bristol, Cardiff, Dundee, Glasgow, London, Swansea
- Age
- 18 years to 99 years
- People
- 2,800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Birmingham, Bradford, Coventry, Derby, Dorchester, Liverpool, London, Londonderry, Salford, Shrewsbury, Stoke-on-Trent, Wolverhampton
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - Phase 3Taking peopleA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Aberdeen, Cardiff, Corby, Coventry, Dundee, Glasgow, Leicester, Liverpool, London, Metropolitan Borough of Wirral, Northwood, Nottingham, Portsmouth, Shipley, Swansea, Thetford, York
- Age
- 18 years and over
- People
- 7,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - Phase 3Taking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Blackpool, Glasgow, Hull, Penzance, Sandbach, Thetford, Whitney
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - No phaseTaking peoplePragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
- Where
- Airdrie, Birkenhead, Birmingham, Bradford, Brighton, Bury St Edmunds, Cambridge, Canterbury, Cardiff, Carlisle, Carshalton, Cheltenham, Cosham, Coventry, Derby, Doncaster, Dorchester, Dudley, Exeter, Glasgow, Great Yarmouth, Hull, Inverness, Ipswich, Kilmarnock, Leicester, Liverpool, London, Manchester, Middlesbrough, Newcastle upon Tyne, Nottingham, Plymouth, Reading, Salford, Sheffield, Shrewsbury, Southend-on-Sea, Stevenage, Stoke-on-Trent, Sunderland, Wolverhampton, York
- Age
- 18 years and over
- People
- 3,600 worldwide
- Run by
- The University of Queensland
See details and how to joinNCT03573089 - Phase 3Taking peopleA Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
- Where
- Glasgow, Leeds, London, Southampton
- Age
- 2 years to 17 years
- People
- 24 worldwide
- Run by
- Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00 - Phase 2Taking peopleA Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
- Where
- Leicester, London
- Age
- 18 years to 68 years
- People
- 74 worldwide
- Run by
- Maze Therapeutics
See details and how to joinNCT06830629 - Phase 1Taking peopleStudy of BHV-1400 in IgA Nephropathy
- Where
- Leicester
- Age
- 18 years to 65 years
- People
- 20 worldwide
- Run by
- Biohaven Therapeutics Ltd.
See details and how to joinNCT07054684 - Phase 3Taking peopleEfficacy and Safety of XyloCore Peritoneal Dialysis Solution.
- Where
- Birmingham, Bradford, Brighton, Canterbury, London, Oxford, Sheffield, Stoke-on-Trent
- Age
- 18 years and over
- People
- 170 worldwide
- Run by
- Iperboreal Pharma Srl
See details and how to joinNCT03994471 - No phaseTaking peopleAutomated Insulin Delivery in Adults With Advanced Kidney Disease
- Where
- London
- Age
- 18 years to 70 years
- People
- 12
- Run by
- Imperial College London
See details and how to joinNCT06463483 - Phase 2WithdrawnSafety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
- Where
- London
- People
- 28 worldwide
- Run by
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
See details and how to joinNCT04580420 - Phase 4Taking peopleRandomised Evaluation of Sodium Dialysate Levels on Vascular Events
- Where
- Altrincham, Ashton-under-Lyne, Barnet, Barnsley, Bath, Bedford, Bexhill-on-Sea, Blackley, Bolton, Bradford, Bridgwater, Brighton, Bristol, Bromley, Broomfield, Cannock, Chesterfield, Clacton-on-Sea, Colchester, Coventry, Crawley, Crewe, Cromer, Darlington, Dartford, Dover, Edgware, Epsom, Exeter, Farnborough, Gloucester, Great Yarmouth, Grimsby, Harlow, Hayes, Honiton, Houghton Regis, Hull, Isleworth, Kingston, London, Ludlow, Macclesfield, Manchester, Margate, Middlesbrough, Northallerton, North Yorks, Nuneaton, Oldham, Plaistow, Polegate, Rochdale, Romford, Rotherham, Rugby, Salford, Scarborough, Scunthorpe, Sheffield, Shrewsbury, Smethwick, Stafford, St Albans, Stevenage, Stockport, Stockton-on-Tees, Stoke-on-Trent, Stratford-upon-Avon, Sutton, Taunton, Telford, Thornton Heath, Torquay, Tottenham, Wigan, Willesborough, Wolverhampton, Woolwich, Worthing, York
- Age
- 18 years and over
- People
- 50,000 worldwide
- Run by
- University of Sydney
See details and how to joinNCT02823821 - Phase 2Not yet taking people in United KingdomPrevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia
- Where
- London
- Age
- 18 years and over
- People
- 69 worldwide
- Run by
- Steno Diabetes Center Copenhagen
See details and how to joinNCT06147232 · EU 2023-509450-55-01 - No phaseNot yet taking people in United KingdomUnderstanding Physical Activity and Quality of Life in Children and Young People with Chronic Kidney Disease
- Where
- Glasgow
- Age
- 6 years to 18 years
- People
- 20
- Run by
- Queen Margaret University
See details and how to joinNCT06677021